{"id":2253,"date":"2017-03-02T00:00:00","date_gmt":"2017-03-02T00:00:00","guid":{"rendered":"http:\/\/www.pharma-mkting.comindex.php\/2017\/03\/02\/pinup030217\/"},"modified":"2019-02-06T02:14:36","modified_gmt":"2019-02-06T02:14:36","slug":"pinup030217","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup030217\/","title":{"rendered":"PinUp: WebMD &amp; pharma&#8217;s Digital ad spend, FDA defends DTC studies, right-to-try survey results , more&#8230;"},"content":{"rendered":"<p><b>Pharma Industry News Update<\/b>: 2 March 2017<\/p>\n<hr\/>\n<p>        &#8220;Same Amount of Eggs, More Baskets&#8221; &#8211; Lesson Learned by WebMD re Pharma Digital Spending<\/p>\n<p>                        <img decoding=\"async\" vspace=\"0\" border=\"0\" hspace=\"0\" style=\"display: block; height: auto !important;\" width=\"500\" src=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2017\/03\/Digital-Ad-Baskets.jpg\"\/>                          <br \/>From www.fiercepharma.com<\/p>\n<p>        With a collective head smack last week, pharma industry digital insiders read about WebMD&#8217;s decision to pursue a sale or merger after some reports blamed the move on slowing pharma spending on digital marketing. <\/p>\n<p>Wendy Blackburn, executive VP at Intouch solutions, said people do turn to WebMD to research medical conditions, but placing banners there has not proven effective, in part because advertisers have to spend large amount of money to get eyeballs.<\/p>\n<p>&#8220;Sites with an over dependence on ad revenue will feel the same pain. The cause is not a sudden decrease in pharma media investments, it&#8217;s a gradual increase in the diversification of those investments. Same amount of eggs, more baskets,&#8221; Doug Weinbrenner, VP and engagement strategy director at FCB Health&#8217;s Area 23, said in an interview.<\/p>\n<p><a href=\"http:\/\/sco.lt\/8U1Kj3\">More here&#8230;<\/a><\/p>\n<p>Further Reading:<\/p>\n<ul>\n<li><a href=\"http:\/\/sco.lt\/5I0bSr\">WebMD is Nothing Special for Pharma Ad Buyers!<\/a><\/li>\n<li><a href=\"http:\/\/sco.lt\/88fy7t\">The Disappeared WebMD Online Health Community Moderators<\/a><\/li>\n<li><a href=\"http:\/\/sco.lt\/7t6TXF\">Is WebMD Too Cozy with Big Pharma?<\/a><\/li>\n<\/ul>\n<hr\/>\n<p>        <img loading=\"lazy\" decoding=\"async\" height=\"1\" vspace=\"0\" border=\"0\" hspace=\"0\" width=\"5\" class=\"SpacerImage\" src=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2019\/02\/S.gif\"\/>                              <img decoding=\"async\" vspace=\"0\" border=\"0\" hspace=\"0\" style=\"display: block; height: auto !important;\" width=\"300\" src=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2017\/03\/KathrynAikin.jpg\"\/>                          FDA&#8217;s Chief Psychologist Defends DTC Advertising Studies<\/p>\n<p>From www.fda.gov<\/p>\n<p>In a blog post, Senior Social Science Analyst and Team Lead Kathryn Aikin, Ph.D., described the direct-to-consumer (DTC) research conducted in support of FDA&#8217;s mission. One revealing insight: her team sometimes offers FREE advice to pharma marketers regarding promotions before they are disseminated. <\/p>\n<p>&#8220;We look at DTC ads, as well as materials designed for health care professionals. Our job is to support the agency&#8217;s goal of providing science-based information and maintaining its commitment to public health. We provide social science data meant to inform regulatory actions or guidances. <b>Sometimes we offer advice to companies on their DTC materials before they disseminate them<\/b>, but only at their request. That is completely voluntary.&#8221;<\/p>\n<p>What research is in progress or on the horizon? <a href=\"http:\/\/sco.lt\/4wnmNd\">More here&#8230;<\/a><\/p>\n<p>Further Reading:<\/p>\n<ul>\n<li><a href=\"http:\/\/bit.ly\/mascotgallery\">Gallery of Drug Advertising Mascots<\/a><\/li>\n<li><a href=\"http:\/\/sco.lt\/7afJmD\">Is DTC Drug Advertising Effective? More &amp; BETTER Research is Necessary<\/a><\/li>\n<li><a href=\"http:\/\/sco.lt\/6Q6mYr\">FDA Needs to Do a Better Job Communicating DTC Research Results, Says Expert<\/a><\/li>\n<li><a href=\"http:\/\/sco.lt\/79jkrx\">Fact Checking Puzzling Criticisms of a &#8220;Puzzling&#8221; DTC Study Proposed by FDA<\/a><\/li>\n<\/ul>\n<hr\/>\n<p>        Is &#8220;Right to Try&#8221; a Good Idea? Survey Results<\/p>\n<p>                        <img decoding=\"async\" vspace=\"0\" border=\"0\" hspace=\"0\" style=\"display: block; height: auto !important;\" width=\"500\" src=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2017\/03\/FDA-Slow-and-Burdensome-v-Right-to-Try-SurveyResults.jpg\"\/>                          <br \/>From pharmamkting.blogspot.com<\/p>\n<p>        In his address to Congress, President Trump called on the FDA to speed the approval of drugs to treat life-threatening diseases, &#8220;deriding the agency&#8217;s current process as &#8216;slow and burdensome&#8217;,&#8221; according to t<a href=\"http:\/\/sco.lt\/8bbHJB\">his STATnews article<\/a>. <\/p>\n<p>One solution to alleviating FDA&#8217;s &#8220;slow and burdensome&#8221; approval process and getting potentially life-saving drugs to patients is &#8220;Right to Try&#8221; laws that would allow people with fatal illnesses to gain access to experimental medicines, even though they are not enrolled in a clinical trial. VP Pence and other lawmakers support this approach (see <a href=\"http:\/\/bit.ly\/LI-Pence\">here<\/a>). <\/p>\n<p>I decided to ask my readers if they think this is a good idea or not and to also submit comments to support their views.<\/p>\n<p>So far, I&#8217;ve received nearly 50 responses to my survey and more than 30 interesting comments, both pro and con. I share some of these comments <a href=\"http:\/\/bit.ly\/R2T-SurveyResults\">here&#8230;<\/a>             <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Welcome to the March 2, 2017, issue of Pharma Industry News Update (aka PinUp). PinUp is published every Tuesday and Friday as part of your Pharma Marketing News subscription service. It features curated pharma industry news and views of topical interest from a variety of sources.<\/p>\n","protected":false},"author":2,"featured_media":2713,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[15],"tags":[],"topic":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>PinUp: WebMD &amp; pharma&#039;s Digital ad spend, FDA defends DTC studies, right-to-try survey results , more... - Pharma Marketing Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup030217\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PinUp: WebMD &amp; pharma&#039;s Digital ad spend, FDA defends DTC studies, right-to-try survey results , more... - Pharma Marketing Network\" \/>\n<meta property=\"og:description\" content=\"Welcome to the March 2, 2017, issue of Pharma Industry News Update (aka PinUp). PinUp is published every Tuesday and Friday as part of your Pharma Marketing News subscription service. It features curated pharma industry news and views of topical interest from a variety of sources.\" \/>\n<meta property=\"og:url\" content=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup030217\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Marketing Network\" \/>\n<meta property=\"article:published_time\" content=\"2017-03-02T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-02-06T02:14:36+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2017\/03\/FDA-Slow-and-Burdensome-v-Right-to-Try-SurveyResults.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"299\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pharma Guy\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pharma Guy\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup030217\/\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup030217\/\",\"name\":\"PinUp: WebMD &amp; pharma's Digital ad spend, FDA defends DTC studies, right-to-try survey results , more... - Pharma Marketing Network\",\"isPartOf\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\"},\"datePublished\":\"2017-03-02T00:00:00+00:00\",\"dateModified\":\"2019-02-06T02:14:36+00:00\",\"author\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\"},\"breadcrumb\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup030217\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup030217\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup030217\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PinUp: WebMD &amp; pharma&#8217;s Digital ad spend, FDA defends DTC studies, right-to-try survey results , more&#8230;\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\",\"name\":\"Pharma Marketing Network\",\"description\":\"Pharma Marketing Network\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\",\"name\":\"Pharma Guy\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/\",\"url\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"contentUrl\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"caption\":\"Pharma Guy\"},\"description\":\"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PinUp: WebMD &amp; pharma's Digital ad spend, FDA defends DTC studies, right-to-try survey results , more... - Pharma Marketing Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup030217\/","og_locale":"en_US","og_type":"article","og_title":"PinUp: WebMD &amp; pharma's Digital ad spend, FDA defends DTC studies, right-to-try survey results , more... - Pharma Marketing Network","og_description":"Welcome to the March 2, 2017, issue of Pharma Industry News Update (aka PinUp). PinUp is published every Tuesday and Friday as part of your Pharma Marketing News subscription service. It features curated pharma industry news and views of topical interest from a variety of sources.","og_url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup030217\/","og_site_name":"Pharma Marketing Network","article_published_time":"2017-03-02T00:00:00+00:00","article_modified_time":"2019-02-06T02:14:36+00:00","og_image":[{"width":600,"height":299,"url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2017\/03\/FDA-Slow-and-Burdensome-v-Right-to-Try-SurveyResults.jpg","type":"image\/jpeg"}],"author":"Pharma Guy","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pharma Guy","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup030217\/","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup030217\/","name":"PinUp: WebMD &amp; pharma's Digital ad spend, FDA defends DTC studies, right-to-try survey results , more... - Pharma Marketing Network","isPartOf":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website"},"datePublished":"2017-03-02T00:00:00+00:00","dateModified":"2019-02-06T02:14:36+00:00","author":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1"},"breadcrumb":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup030217\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup030217\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup030217\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/"},{"@type":"ListItem","position":2,"name":"PinUp: WebMD &amp; pharma&#8217;s Digital ad spend, FDA defends DTC studies, right-to-try survey results , more&#8230;"}]},{"@type":"WebSite","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/","name":"Pharma Marketing Network","description":"Pharma Marketing Network","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1","name":"Pharma Guy","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/","url":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","contentUrl":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","caption":"Pharma Guy"},"description":"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/"}]}},"_links":{"self":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/2253"}],"collection":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/comments?post=2253"}],"version-history":[{"count":1,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/2253\/revisions"}],"predecessor-version":[{"id":2714,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/2253\/revisions\/2714"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media\/2713"}],"wp:attachment":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media?parent=2253"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/categories?post=2253"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/tags?post=2253"},{"taxonomy":"topic","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/topic?post=2253"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}